Prostanozol

Prostanozol is a steroid that was first synthesized in the 1970s by Syntex, a multinational pharmaceutical company. It is a derivative of dihydrotestosterone (DHT), a naturally occurring hormone in the human body. Prostanozol is classified as an anabolic steroid, which means it promotes muscle growth.

History[edit | edit source]

Prostanozol was first synthesized in the 1970s by Syntex, a pharmaceutical company that was also responsible for the creation of other notable steroids such as Oxymetholone and Methandrostenolone. Despite its synthesis, Prostanozol was never marketed by Syntex and remained relatively unknown until the early 2000s.

Pharmacology[edit | edit source]

As a derivative of DHT, Prostanozol shares many of the same properties. It is an anabolic steroid, which means it promotes the growth of muscle tissue. However, unlike many other anabolic steroids, Prostanozol does not convert into estrogen in the body, which can lead to side effects such as water retention and gynecomastia.

Legal Status[edit | edit source]

In many countries, including the United States, Prostanozol is classified as a controlled substance. This means it is illegal to possess, use, or distribute without a prescription or license. In the world of professional sports, Prostanozol is banned by most major athletic organizations due to its performance-enhancing effects.

Side Effects[edit | edit source]

Like all anabolic steroids, Prostanozol can have serious side effects. These can include liver damage, cardiovascular issues, changes in mood and behavior, and in men, shrinkage of the testicles and development of breast tissue. Long-term use can also lead to dependency and withdrawal symptoms.